Clinical Trials
4
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:2
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (50.0%)Phase 1
2 (50.0%)A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
Not Applicable
Not yet recruiting
- Conditions
- Sjögren's Syndrome
- Interventions
- Drug: Vehicle Control
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Lubris Bio Pty Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT07118241
- Locations
- 🇦🇺
Sydney Eye Hospital, Sydney, New South Wales, Australia
🇦🇺Univ of New South Wales, Sydney, New South Wales, Australia
🇦🇺OTA, Brisbane, Queensland, Australia
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
Not Applicable
Not yet recruiting
- Conditions
- Ocular Graft Versus Host Disease
- Interventions
- Drug: rhPRG4 450ug/mlDrug: Vehicle Control
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Lubris Bio Pty Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT07118254
- Locations
- 🇦🇺
Sydney Eye Hospital, Sydney, New South Wales, Australia
🇦🇺OTA, Brisbane, Queensland, Australia
🇦🇺Royal Melbourne Hospital, Melbourne, Victoria, Australia
RHPRG4 FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
Phase 1
Not yet recruiting
- Conditions
- Sjogren's Syndrome With Dry Eye
- Interventions
- Drug: rhPRG4 (450 µg/mL)Drug: Vehicle
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Lubris Bio Pty Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT06520202
RHPRG4 FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Lubris Bio Pty Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT06495307
News
No news found